Panacea Biotec Board to Consider Q2 Results on 14th Nov'26
Panacea Biotec Ltd 路 Intimation 路 14 Nov 2026, 5:30 am
Panacea Biotec Board to Consider Q2 Results on 14th Nov'26 Panacea Biotec announced that a meeting of its Board of Directors is scheduled for 14th Nov'26 to consider and approve the standalone and consolidated unaudited financial results for the quarter and half-year ended 30th Sep'26. Additionally, the company confirmed that the trading window for designated persons and their immediate relatives remains closed from 1st Oct'26 through 16th Nov'26 in compliance with insider trading regulations.
Original exchange filing (PDF)
More announcements from Panacea Biotec Ltd
- Please find attached Unaudited Financial Results for quarter and half year ended September 30, 2026 路 15 Nov 2026
- Panacea Biotec Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 15 Nov 2026
- We would like to inform you that the Board of Directors has at its meeting held today, i.e. Saturday, November 14, 2026, inter-alia, considered and approved the Standalone and Consolidated .... 路 15 Nov 2026
- PANACEA BIOTEC LIMITED has informed the Exchange about Board Meeting to be held on 14-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . 路 14 Nov 2026
- PANACEA BIOTEC LIMITED has informed the Exchange about Board Meeting to be held on 14-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . 路 14 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 路 14 Nov 2026
- Please find attached details of shares dematerialised during September 2026 under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 路 07 Oct 2026
- Please find attached voting results of 42nd Annual General Meeting of the Company held on 29.09.2026 along with Scrutinizer''s Report 路 02 Oct 2026
